Literature DB >> 11562190

Triple, MPEG-conjugated, helix-forming oligonucleotides (TRIPEGXs): liquid-phase synthesis of natural and chimeric "all-purine" sequences linked to high molecular weight poly(ethylene glycols).

M Ballico1, S Drioli, F Morvan, L Xodo, G M Bonora.   

Abstract

Long "all-purine" oligonucleotides, up to the 20mer, known to be active as antigene effectors, conjugated to high molecular weight monomethoxy poly(ethylene glycol)s (MPEG)s, were successfully synthesized. Through a liquid-phase, MPEG-supported process, both natural and chimeric sequences containing selected phosphorothioate backbone modifications were obtained, purified, and characterized. To follow their cellular trafficking, a fluorescent probe was linked by soluble supported organic reactions to the 5'-terminus, and the efficiency of the different synthetic procedures for the introduction of a fluorescein moiety was compared. The usefulness of the fluorescent marker was estimated by laser confocal microscopy that ascertains that the MPEG-conjugation enhances the oligonucleotide capacity to cross the cellular membranes and to be accumulated inside the nuclei.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11562190     DOI: 10.1021/bc010034b

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  3 in total

Review 1.  Synthesis of oligonucleotides on a soluble support.

Authors:  Harri Lönnberg
Journal:  Beilstein J Org Chem       Date:  2017-07-12       Impact factor: 2.883

Review 2.  Preparation of trinucleotide phosphoramidites as synthons for the synthesis of gene libraries.

Authors:  Ruth Suchsland; Bettina Appel; Sabine Müller
Journal:  Beilstein J Org Chem       Date:  2018-02-13       Impact factor: 2.883

3.  Acetylated and methylated β-cyclodextrins as viable soluble supports for the synthesis of short 2′-oligodeoxyribo-nucleotides in solution.

Authors:  Alejandro Gimenez Molina; Vyacheslav Kungurtsev; Pasi Virta; Harri Lönnberg
Journal:  Molecules       Date:  2012-10-16       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.